Business Context and Reporting Period
Puma Biotechnology, Inc. filed this Form 8-K on December 7, 2011, to report the entry into a material definitive agreement. The company is a Delaware corporation headquartered in Los Angeles, California.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a new lease agreement.
Material Changes
The company entered into a seven-year Office Lease for approximately 13,254 rentable square feet at 10880 Wilshire Boulevard, Los Angeles, to serve as its new headquarters. The lease is expected to commence on or about December 19, 2011.
- Initial Term: Seven years.
- Base Rent (Year 1): Approximately $44,400 per month.
- Base Rent (Year 7): Approximately $53,000 per month.
- Extension Option: The company has an option to extend the lease for an additional five-year term at then-prevailing market rates.
Guidance, Outlook, and Risks
The filing contains no financial guidance, management commentary on future performance, or discussion of risks and contingencies beyond the terms of the lease agreement. No unusual items were reported.
Investor Verification Checklist
- Verify the full text of the Office Lease filed as Exhibit 10.1 for complete terms and conditions.
- Confirm the actual commencement date of the lease relative to the expected date of December 19, 2011.
- Review subsequent filings to determine if the company exercised the five-year extension option.